News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
839,846 Results
Type
Article (86126)
Company Profile (649)
Press Release (753071)
Multimedia
Podcasts (129)
Webinars (14)
Section
Business (232268)
Career Advice (4125)
Deals (39712)
Drug Delivery (126)
Drug Development (90805)
Employer Resources (198)
FDA (18004)
Job Trends (17326)
News (395632)
Policy (39677)
Tag
Academia (2992)
Academic (1)
Accelerated approval (6)
Adcomms (25)
Allergies (81)
Alliances (56687)
ALS (80)
Alzheimer's disease (1475)
Antibody-drug conjugate (ADC) (144)
Approvals (17996)
Artificial intelligence (228)
Autoimmune disease (27)
Automation (12)
Bankruptcy (403)
Best Places to Work (12511)
BIOSECURE Act (22)
Biosimilars (119)
Biotechnology (447)
Bladder cancer (76)
Brain cancer (27)
Breast cancer (235)
Cancer (2072)
Cardiovascular disease (143)
Career advice (3532)
Career pathing (34)
CAR-T (161)
Cell therapy (449)
Cervical cancer (17)
Clinical research (72890)
Collaboration (798)
Compensation (451)
Complete response letters (28)
COVID-19 (2836)
CRISPR (44)
C-suite (226)
Cystic fibrosis (99)
Data (1910)
Decentralized trials (2)
Denatured (45)
Depression (39)
Diabetes (192)
Diagnostics (6768)
Digital health (10)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (121)
Drug pricing (96)
Drug shortages (17)
Duchenne muscular dystrophy (84)
Earnings (95498)
Editorial (37)
Employer branding (25)
Employer resources (167)
Events (128669)
Executive appointments (636)
FDA (18984)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (670)
Gene editing (101)
Generative AI (22)
Gene therapy (319)
GLP-1 (741)
Government (5110)
Grass and pollen (4)
Guidances (42)
Healthcare (20751)
Huntington's disease (25)
IgA nephropathy (29)
Immunology and inflammation (129)
Indications (25)
Infectious disease (2952)
Inflammatory bowel disease (150)
Inflation Reduction Act (11)
Influenza (44)
Intellectual property (88)
Interviews (812)
IPO (17749)
IRA (38)
Job creations (5186)
Job search strategy (2861)
Kidney cancer (11)
Labor market (41)
Layoffs (543)
Leadership (22)
Legal (10063)
Liver cancer (73)
Lung cancer (295)
Lymphoma (138)
Machine learning (6)
Management (65)
Manufacturing (294)
MASH (69)
Medical device (14339)
Medtech (14344)
Mergers & acquisitions (22321)
Metabolic disorders (607)
Multiple sclerosis (80)
NASH (22)
Neurodegenerative disease (102)
Neuropsychiatric disorders (23)
Neuroscience (1983)
NextGen: Class of 2025 (7666)
Non-profit (5058)
Now hiring (40)
Obesity (328)
Opinion (271)
Ovarian cancer (70)
Pain (72)
Pancreatic cancer (68)
Parkinson's disease (135)
Partnered (20)
Patents (206)
Patient recruitment (96)
Peanut (48)
People (64947)
Pharmaceutical (131)
Pharmacy benefit managers (13)
Phase I (22525)
Phase II (31693)
Phase III (23821)
Pipeline (1052)
Policy (142)
Postmarket research (3542)
Preclinical (10161)
Press Release (72)
Prostate cancer (93)
Psychedelics (34)
Radiopharmaceuticals (255)
Rare diseases (369)
Real estate (7384)
Recruiting (75)
Regulatory (26453)
Reports (57)
Research institute (2647)
Resumes & cover letters (649)
Rett syndrome (2)
RNA editing (5)
RSV (34)
Schizophrenia (70)
Series A (127)
Series B (74)
Service/supplier (25)
Sickle cell disease (47)
Special edition (18)
Spinal muscular atrophy (164)
Sponsored (34)
Startups (4286)
State (2)
Stomach cancer (12)
Supply chain (53)
Tariffs (38)
The Weekly (82)
Vaccines (737)
Venture capitalists (41)
Weight loss (228)
Women's health (37)
Worklife (20)
Date
Today (137)
Last 7 days (738)
Last 30 days (2237)
Last 365 days (29583)
2025 (9112)
2024 (34412)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1265)
Alabama (54)
Alaska (6)
Arizona (250)
Arkansas (8)
Asia (49880)
Australia (8798)
California (5462)
Canada (1624)
China (503)
Colorado (176)
Connecticut (221)
Delaware (132)
Europe (114164)
Florida (716)
Georgia (151)
Hawaii (1)
Idaho (64)
Illinois (459)
India (25)
Indiana (279)
Iowa (10)
Japan (138)
Kansas (111)
Kentucky (17)
Louisiana (8)
Maine (67)
Maryland (869)
Massachusetts (4286)
Michigan (187)
Minnesota (325)
Mississippi (2)
Missouri (55)
Montana (25)
Nebraska (26)
Nevada (55)
New Hampshire (51)
New Jersey (1544)
New Mexico (28)
New York (1552)
North Carolina (1020)
North Dakota (8)
Northern California (2357)
Ohio (168)
Oklahoma (13)
Oregon (45)
Pennsylvania (1168)
Puerto Rico (12)
Rhode Island (24)
South America (1648)
South Carolina (10)
South Dakota (1)
Southern California (2041)
Tennessee (42)
Texas (756)
United States (20570)
Utah (121)
Virginia (108)
Washington D.C. (40)
Washington State (522)
West Virginia (2)
Wisconsin (45)
839,846 Results for "mirus bio llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Mirus Bio Named a Top Workplace by the Wisconsin State Journal
Mirus Bio has been named a Top Workplace 2024 by Wisconsin State Journal Top Workplaces.
March 26, 2024
·
2 min read
BioMidwest
Gamma Biosciences Announces Sale of Mirus Bio to Merck KGaA, Darmstadt, Germany, for $600 Million
Gamma Biosciences announced that it has entered into an agreement with Merck KGaA, Darmstadt, Germany, a leading science and technology company, whereby Merck KGaA, Darmstadt, Germany, will acquire Gamma operating company Mirus Bio for $600 million in cash.
May 23, 2024
·
4 min read
BioMidwest
Mirus Bio Receives ISO 13485:2016 Certification
Mirus Bio today announced that its quality management system (QMS) has achieved ISO 13485:2016 certification.
January 31, 2024
·
2 min read
Deals
MilliporeSigma Signs Definitive Agreement to Acquire Mirus Bio, Furthering Ambition to Be a Leading Supplier for Viral Vector Manufacturing
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, today announced the signing of a definitive agreement to acquire Mirus Bio for US$ 600 million.
May 22, 2024
·
4 min read
BioMidwest
Mirus Bio Launches RevIT™ AAV Enhancer
Mirus Bio, a life sciences company developing innovative solutions for nucleic acid delivery to support cell and gene therapy production, biopharmaceutical manufacturing, and research applications, announced the launch of the RevIT AAV Enhancer.
August 3, 2023
·
3 min read
Neuroscience
GSK Dives Deeper Into Neuro With $2.5B+ ABL Bio Pact
GSK is paying to access ABL Bio’s Grabody-B platform, which potentially enables therapies to cross the blood-brain barrier.
April 7, 2025
·
2 min read
·
Tristan Manalac
Pharm Country
MiRus Siegel™ TAVR: First in Human Results Presented at New York Valves
Pradeep K. Yadav MD, Director of Structural Interventions, Piedmont Heart Institute, Atlanta presented the initial experience with the MiRus Siegel™ 8-Fr aortic transcatheter heart valve (THV) at the New York Valves conference.
June 6, 2024
·
3 min read
Press Releases
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711
April 22, 2025
·
2 min read
Press Releases
Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711 - April 25, 2025
April 28, 2025
·
3 min read
Immunology and inflammation
Hillstar Bio Nets $67M Series A to Advance Autoimmune and Arthritis Pipeline
Led by alums from Takeda and Boston Pharmaceuticals, Hillstar Bio is working on treatments that remove harmful immune cells to relieve disease.
March 25, 2025
·
2 min read
·
Dan Samorodnitsky
1 of 83,985
Next
